Skip to main content
NCBI home page
Neuroscience Bulletin logoLink to Neuroscience Bulletin
. 2012 Feb 29;28(2):131–144. doi: 10.1007/s12264-012-1219-5

Emerging role of Toll-like receptors in the control of pain and itch

Tong Liu 1,✉, Yong-Jing Gao 1,2, Ru-Rong Ji 1,✉
PMCID: PMC3347759  NIHMSID: NIHMS373822  PMID: 22466124

Abstract

Toll-like receptors (TLRs) are germline-encoded pattern-recognition receptors that initiate innate immune responses by recognizing molecular structures shared by a wide range of pathogens, known as pathogen-associated molecular patterns (PAMPs). After tissue injury or cellular stress, TLRs also detect endogenous ligands known as danger-associated molecular patterns (DAMPs). TLRs are expressed in both non-neuronal and neuronal cell types in the central nervous system (CNS) and contribute to both infectious and non-infectious disorders in the CNS. Following tissue insult and nerve injury, TLRs (such as TLR2, TLR3, and TLR4) induce the activation of microglia and astrocytes and the production of the proinflammatory cytokines in the spinal cord, leading to the development and maintenance of inflammatory pain and neuropathic pain. In particular, primary sensory neurons, such as nociceptors, express TLRs (e.g., TLR4 and TLR7) to sense exogenous PAMPs and endogenous DAMPs released after tissue injury and cellular stress. These neuronal TLRs are new players in the processing of pain and itch by increasing the excitability of primary sensory neurons. Given the prevalence of chronic pain and itch and the suffering of affected people, insights into TLR signaling in the nervous system will open a new avenue for the management of clinical pain and itch.

Keywords: astrocytes, microglia, Toll-like receptor, pain, itch, danger-associated molecular patterns, pathogen-associated molecular patterns

Contributor Information

Tong Liu, Phone: +1-617-7328852, FAX: +1-617-7302801, Email: tliu5@partners.org.

Ru-Rong Ji, Phone: +1-617-7328852, FAX: +1-617-7302801, Email: rrji@zeus.bwh.harvard.edu.

References

  • [1].Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell. 2006;124:783–801. doi: 10.1016/j.cell.2006.02.015. [DOI] [PubMed] [Google Scholar]
  • [2].Mills K.H. TLR-dependent T cell activation in autoimmunity. Nat Rev Immunol. 2011;11:807–822. doi: 10.1038/nri3095. [DOI] [PubMed] [Google Scholar]
  • [3].Anderson K.V., Jurgens G., Nusslein-Volhard C. Establishment of dorsal-ventral polarity in the Drosophila embryo: genetic studies on the role of the Toll gene product. Cell. 1985;42:779–789. doi: 10.1016/0092-8674(85)90274-0. [DOI] [PubMed] [Google Scholar]
  • [4].Lemaitre B., Nicolas E., Michaut L., Reichhart J.M., Hoffmann J.A. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell. 1996;86:973–983. doi: 10.1016/S0092-8674(00)80172-5. [DOI] [PubMed] [Google Scholar]
  • [5].Medzhitov R., Janeway C., Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev. 2000;173:89–97. doi: 10.1034/j.1600-065X.2000.917309.x. [DOI] [PubMed] [Google Scholar]
  • [6].Kawai T., Akira S. The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors. Nat Immunol. 2010;11:373–384. doi: 10.1038/ni.1863. [DOI] [PubMed] [Google Scholar]
  • [7].Oosting M., Ter H.H., Sturm P., Adema G.J., Kullberg B.J., van der Meer J.W., et al. TLR1/TLR2 heterodimers play an important role in the recognition of Borrelia spirochetes. PLoS One. 2011;6:e25998. doi: 10.1371/journal.pone.0025998. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [8].Triantafilou M., Uddin A., Maher S., Charalambous N., Hamm T.S., Alsumaiti A., et al. Anthrax toxin evades Toll-like receptor recognition, whereas its cell wall components trigger activation via TLR2/6 heterodimers. Cell Microbiol. 2007;9:2880–2892. doi: 10.1111/j.1462-5822.2007.01003.x. [DOI] [PubMed] [Google Scholar]
  • [9].Alexopoulou L., Thomas V., Schnare M., Lobet Y., Anguita J., Schoen R.T., et al. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat Med. 2002;8:878–884. doi: 10.1038/nm732. [DOI] [PubMed] [Google Scholar]
  • [10].Yamamoto M., Sato S., Mori K., Hoshino K., Takeuchi O., Takeda K., et al. Cutting edge: a novel Toll/IL-1 receptor domain-containing adapter that preferentially activates the IFN-beta promoter in the Toll-like receptor signaling. J Immunol. 2002;169:6668–6672. doi: 10.4049/jimmunol.169.12.6668. [DOI] [PubMed] [Google Scholar]
  • [11].Diebold S.S., Kaisho T., Hemmi H., Akira S., Reis e Sousa C. Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science. 2004;303:1529–1531. doi: 10.1126/science.1093616. [DOI] [PubMed] [Google Scholar]
  • [12].Town T., Jeng D., Alexopoulou L., Tan J., Flavell R.A. Microglia recognize double-stranded RNA via TLR3. J Immunol. 2006;176:3804–3812. doi: 10.4049/jimmunol.176.6.3804. [DOI] [PubMed] [Google Scholar]
  • [13].Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature. 2001;413:732–738. doi: 10.1038/35099560. [DOI] [PubMed] [Google Scholar]
  • [14].Heil F., Hemmi H., Hochrein H., Ampenberger F., Kirschning C., Akira S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science. 2004;303:1526–1529. doi: 10.1126/science.1093620. [DOI] [PubMed] [Google Scholar]
  • [15].Shimazu R., Akashi S., Ogata H., Nagai Y., Fukudome K., Miyake K., et al. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J Exp Med. 1999;189:1777–1782. doi: 10.1084/jem.189.11.1777. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [16].Poltorak A., He X., Smirnova I., Liu M.Y., Van H.C., Du X., et al. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science. 1998;282:2085–2088. doi: 10.1126/science.282.5396.2085. [DOI] [PubMed] [Google Scholar]
  • [17].Hayashi F., Smith K.D., Ozinsky A., Hawn T.R., Yi E.C., Goodlett D.R., et al. The innate immune response to bacterial flagellin is mediated by Toll-like receptor 5. Nature. 2001;410:1099–1103. doi: 10.1038/35074106. [DOI] [PubMed] [Google Scholar]
  • [18].Hemmi H., Takeuchi O., Kawai T., Kaisho T., Sato S., Sanjo H., et al. A Toll-like receptor recognizes bacterial DNA. Nature. 2000;408:740–745. doi: 10.1038/35047123. [DOI] [PubMed] [Google Scholar]
  • [19].Krieg A.M. CpG motifs in bacterial DNA and their immune effects. Annu Rev Immunol. 2002;20:709–760. doi: 10.1146/annurev.immunol.20.100301.064842. [DOI] [PubMed] [Google Scholar]
  • [20].Yarovinsky F., Zhang D., Andersen J.F., Bannenberg G.L., Serhan C.N., Hayden M.S., et al. TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science. 2005;308:1626–1629. doi: 10.1126/science.1109893. [DOI] [PubMed] [Google Scholar]
  • [21].Okamura Y., Watari M., Jerud E.S., Young D.W., Ishizaka S.T., Rose J., et al. The extra domain A of fibronectin activates Toll-like receptor4. J Biol Chem. 2001;276:10229–10233. doi: 10.1074/jbc.M100099200. [DOI] [PubMed] [Google Scholar]
  • [22].Imai Y., Kuba K., Neely G.G., Yaghubian-Malhami R., Perkmann T., van L.G., et al. Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury. Cell. 2008;133:235–249. doi: 10.1016/j.cell.2008.02.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [23].Jiang D., Liang J., Fan J., Yu S., Chen S., Luo Y., et al. Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med. 2005;11:1173–1179. doi: 10.1038/nm1315. [DOI] [PubMed] [Google Scholar]
  • [24].Midwood K., Sacre S., Piccinini A.M., Inglis J., Trebaul A., Chan E., et al. Tenascin-C is an endogenous activator of Toll-like receptor 4 that is essential for maintaining inflammation in arthritic joint disease. Nat Med. 2009;15:774–780. doi: 10.1038/nm.1987. [DOI] [PubMed] [Google Scholar]
  • [25].West X.Z., Malinin N.L., Merkulova A.A., Tischenko M., Kerr B.A., Borden E.C., et al. Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands. Nature. 2010;467:972–976. doi: 10.1038/nature09421. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [26].Tian J., Avalos A.M., Mao S.Y., Chen B., Senthil K., Wu H., et al. Tolllike receptor 9-dependent activation by DNA-containing immune complexes is mediated by HMGB1 and RAGE. Nat Immunol. 2007;8:487–496. doi: 10.1038/ni1457. [DOI] [PubMed] [Google Scholar]
  • [27].Biragyn A., Ruffini P.A., Leifer C.A., Klyushnenkova E., Shakhov A., Chertov O., et al. Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2. Science. 2002;298:1025–1029. doi: 10.1126/science.1075565. [DOI] [PubMed] [Google Scholar]
  • [28].Vabulas R.M., Wagner H., Schild H. Heat shock proteins as ligands of toll-like receptors. Curr Top Microbiol Immunol. 2002;270:169–184. doi: 10.1007/978-3-642-59430-4_11. [DOI] [PubMed] [Google Scholar]
  • [29].Kariko K., Ni H., Capodici J., Lamphier M., Weissman D. mRNA is an endogenous ligand for Toll-like receptor 3. J Biol Chem. 2004;279:12542–12550. doi: 10.1074/jbc.M310175200. [DOI] [PubMed] [Google Scholar]
  • [30].Takeuchi O., Akira S. Pattern recognition receptors and inflammation. Cell. 2010;140:805–820. doi: 10.1016/j.cell.2010.01.022. [DOI] [PubMed] [Google Scholar]
  • [31].Akira S., Takeda K. Toll-like receptor signalling. Nat Rev Immunol. 2004;4:499–511. doi: 10.1038/nri1391. [DOI] [PubMed] [Google Scholar]
  • [32].Gao Y.J., Zhang L., Samad O.A., Suter M.R., Yasuhiko K., Xu Z.Z., et al. JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain. J Neurosci. 2009;29:4096–4108. doi: 10.1523/JNEUROSCI.3623-08.2009. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [33].Takeda K., Akira S. TLR signaling pathways. Semin Immunol. 2004;16:3–9. doi: 10.1016/j.smim.2003.10.003. [DOI] [PubMed] [Google Scholar]
  • [34].Yamamoto M., Sato S., Hemmi H., Hoshino K., Kaisho T., Sanjo H., et al. Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway. Science. 2003;301:640–643. doi: 10.1126/science.1087262. [DOI] [PubMed] [Google Scholar]
  • [35].Okun E., Griffioen K.J., Mattson M.P. Toll-like receptor signaling in neural plasticity and disease. Trends Neurosci. 2011;34(5):269–281. doi: 10.1016/j.tins.2011.02.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [36].Buchanan M.M., Hutchinson M., Watkins L.R., Yin H. Toll-like receptor 4 in CNS pathologies. J Neurochem. 2010;114:13–27. doi: 10.1111/j.1471-4159.2010.06736.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [37].Lehnardt S. Innate immunity and neuroinflammation in the CNS: the role of microglia in Toll-like receptor-mediated neuronal injury. Glia. 2010;58:253–263. doi: 10.1002/glia.20928. [DOI] [PubMed] [Google Scholar]
  • [38].van Noort J.M., Bsibsi M. Toll-like receptors in the CNS: implications for neurodegeneration and repair. Prog Brain Res. 2009;175:139–148. doi: 10.1016/S0079-6123(09)17509-X. [DOI] [PubMed] [Google Scholar]
  • [39].Basbaum A.I., Bautista D.M., Scherrer G., Julius D. Cellular and molecular mechanisms of pain. Cell. 2009;139:267–284. doi: 10.1016/j.cell.2009.09.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [40].Nicotra L, Loram LC, Watkins LR, Hutchinson MR. Toll-like receptors in chronic pain. Exp Neurol 2011. [Epub ahead of print] [DOI] [PMC free article] [PubMed]
  • [41].Suh H.S., Brosnan C.F., Lee S.C. Toll-like receptors in CNS viral infections. Curr Top Microbiol Immunol. 2009;336:63–81. doi: 10.1007/978-3-642-00549-7_4. [DOI] [PubMed] [Google Scholar]
  • [42].Caso J.R., Pradillo J.M., Hurtado O., Lorenzo P., Moro M. L. I. Toll-like receptor 4 is involved in brain damage and inflammation after experimental stroke. Circulation. 2007;115:1599–1608. doi: 10.1161/CIRCULATIONAHA.106.603431. [DOI] [PubMed] [Google Scholar]
  • [43].Tahara K., Kim H.D., Jin J.J., Maxwell J.A., Li L., Fukuchi K. Role of toll-like receptor signalling in Abeta uptake and clearance. Brain. 2006;129:3006–3019. doi: 10.1093/brain/awl249. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [44].Prinz M., Garbe F., Schmidt H., Mildner A., Gutcher I., Wolter K., et al. Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest. 2006;116:456–464. doi: 10.1172/JCI26078. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [45].Kim D., Lee S., Lee S.J. Toll-like receptors in peripheral nerve injury and neuropathic pain. Curr Top Microbiol Immunol. 2009;336:169–186. doi: 10.1007/978-3-642-00549-7_10. [DOI] [PubMed] [Google Scholar]
  • [46].Guo L.H., Schluesener H.J. The innate immunity of the central nervous system in chronic pain: the role of Toll-like receptors. Cell Mol Life Sci. 2007;64:1128–1136. doi: 10.1007/s00018-007-6494-3. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [47].Tanga F.Y., Nutile-McMenemy N., Deleo J.A. The CNS role of Tolllike receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A. 2005;102:5856–5861. doi: 10.1073/pnas.0501634102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [48].Kim D., Kim M.A., Cho I.H., Kim M.S., Lee S., Jo E.K., et al. A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem. 2007;282:14975–14983. doi: 10.1074/jbc.M607277200. [DOI] [PubMed] [Google Scholar]
  • [49].Obata K., Katsura H., Miyoshi K., Kondo T., Yamanaka H., Kobayashi K., et al. Toll-like receptor 3 contributes to spinal glial activation and tactile allodynia after nerve injury. J Neurochem. 2008;105:2249–2259. doi: 10.1111/j.1471-4159.2008.05353.x. [DOI] [PubMed] [Google Scholar]
  • [50].Sorge R.E., LaCroix-Fralish M.L., Tuttle A.H., Sotocinal S.G., Austin J.S., Ritchie J., et al. Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice. J Neurosci. 2011;31:15450–15454. doi: 10.1523/JNEUROSCI.3859-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [51].Saito O., Svensson C.I., Buczynski M.W., Wegner K., Hua X.Y., Codeluppi S., et al. Spinal glial TLR4-mediated nociception and production of prostaglandin E(2) and TNF. Br J Pharmacol. 2010;160:1754–1764. doi: 10.1111/j.1476-5381.2010.00811.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [52].Mei X.P., Zhou Y., Wang W., Tang J., Wang W., Zhang H., et al. Ketamine depresses Toll-like receptor 3 signaling in spinal microglia in a rat model of neuropathic pain. Neurosignals. 2011;19:44–53. doi: 10.1159/000324293. [DOI] [PubMed] [Google Scholar]
  • [53].Christianson C.A., Dumlao D.S., Stokes J.A., Dennis E.A., Svensson C.I., Corr M., et al. Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis. Pain. 2011;152:2881–2891. doi: 10.1016/j.pain.2011.09.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [54].Wu F.X., Bian J.J., Miao X.R., Huang S.D., Xu X.W., Gong D.J., et al. Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain. Int J Med Sci. 2010;7:251–259. doi: 10.7150/ijms.7.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [55].Lan L.S., Ping Y.J., Na W.L., Miao J., Cheng Q.Q., Ni M.Z., et al. Down-regulation of Toll-like receptor 4 gene expression by short interfering RNA attenuates bone cancer pain in a rat model. Mol Pain. 2010;6:2. doi: 10.1186/1744-8069-6-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [56].Kuang X., Huang Y., Gu H.F., Zu X.Y., Zou W.Y., Song Z.B., et al. Effects of intrathecal epigallocatechin gallate, an inhibitor of Tolllike receptor 4, on chronic neuropathic pain in rats. Eur J Pharmacol. 2012;676:51–56. doi: 10.1016/j.ejphar.2011.11.037. [DOI] [PubMed] [Google Scholar]
  • [57].Qi J., Buzas K., Fan H., Cohen J.I., Wang K., Mont E., et al. Painful pathways induced by TLR stimulation of dorsal root ganglion neurons. J Immunol. 2011;186:6417–6426. doi: 10.4049/jimmunol.1001241. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [58].Xiao H.S., Huang Q.H., Zhang F.X., Bao L., Lu Y.J., Guo C., et al. Identification of gene expression profile of dorsal root ganglion in the rat peripheral axotomy model of neuropathic pain. Proc Natl Acad Sci U S A. 2002;99:8360–8365. doi: 10.1073/pnas.122231899. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [59].Hokfelt T., Zhang X., Wiesenfeld-Hallin Z. Messenger plasticity in primary sensory neurons following axotomy and its functional implications. Trends Neurosci. 1994;17:22–30. doi: 10.1016/0166-2236(94)90031-0. [DOI] [PubMed] [Google Scholar]
  • [60].Woolf C.J., Salter M.W. Neuronal plasticity: increasing the gain in pain. Science. 2000;288:1765–1769. doi: 10.1126/science.288.5472.1765. [DOI] [PubMed] [Google Scholar]
  • [61].Ji R.R., Kohno T., Moore K.A., Woolf C.J. Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci. 2003;26:696–705. doi: 10.1016/j.tins.2003.09.017. [DOI] [PubMed] [Google Scholar]
  • [62].Tao Y.X. Dorsal horn alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor trafficking in inflammatory pain. Anesthesiology. 2010;112:1259–1265. doi: 10.1097/ALN.0b013e3181d3e1ed. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [63].Stucky C.L., Gold M.S., Zhang X. Mechanisms of pain. Proc Natl Acad Sci U S A. 2001;98:11845–11846. doi: 10.1073/pnas.211373398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [64].Luo F., Wang J.Y. Neuronal nociceptive responses in thalamocortical pathways. Neurosci Bull. 2009;25:289–295. doi: 10.1007/s12264-009-0908-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [65].Liu M.G., Chen J. Roles of the hippocampal formation in pain information processing. Neurosci Bull. 2009;25:237–266. doi: 10.1007/s12264-009-0905-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [66].Li H.L., Qin L.Y., Wan Y. Astrocyte: a new star in pain research. Sheng Li Ke Xue Jin Zhan. 2003;34:45–48. [PubMed] [Google Scholar]
  • [67].Liu F.Y., Sun Y.N., Wang F.T., Li Q., Su L., Zhao Z.F., et al. Activation of satellite glial cells in lumbar dorsal root ganglia contributes to neuropathic pain after spinal nerve ligation. Brain Res. 2012;1427:65–77. doi: 10.1016/j.brainres.2011.10.016. [DOI] [PubMed] [Google Scholar]
  • [68].Suter M.R., Wen Y.R., Decosterd I., Ji R.R. Do glial cells control pain? Neuron Glia Biol. 2007;3:255–268. doi: 10.1017/S1740925X08000100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [69].Ji R.R., Suter M.R. p38 MAPK, microglial signaling, and neuropathic pain. Mol Pain. 2007;3:33. doi: 10.1186/1744-8069-3-33. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [70].Gao Y.J., Ji R.R. Targeting astrocyte signaling for chronic pain. Neurotherapeutics. 2010;7:482–493. doi: 10.1016/j.nurt.2010.05.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [71].Gao Y.J., Ji R.R. Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther. 2010;126:56–68. doi: 10.1016/j.pharmthera.2010.01.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [72].Watkins L.R., Hutchinson M.R., Rice K.C., Maier S.F. The “toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia. Trends Pharmacol Sci. 2009;30:581–591. doi: 10.1016/j.tips.2009.08.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [73].Romero-Sandoval E.A., Horvath R.J., Deleo J.A. Neuroimmune interactions and pain: focus on glial-modulating targets. Curr Opin Investig Drugs. 2008;9:726–734. [PMC free article] [PubMed] [Google Scholar]
  • [74].Zhang F.Y., Wan Y., Zhang Z.K., Light A.R., Fu K.Y. Peripheral formalin injection induces long-lasting increases in cyclooxygenase 1 expression by microglia in the spinal cord. J Pain. 2007;8:110–117. doi: 10.1016/j.jpain.2006.06.006. [DOI] [PubMed] [Google Scholar]
  • [75].Ren K., Dubner R. Interactions between the immune and nervous systems in pain. Nat Med. 2010;16:1267–1276. doi: 10.1038/nm.2234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [76].Scholz J., Woolf C.J. The neuropathic pain triad: neurons, immune cells and glia. Nat Neurosci. 2007;10:1361–1368. doi: 10.1038/nn1992. [DOI] [PubMed] [Google Scholar]
  • [77].Tsuda M., Inoue K., Salter M.W. Neuropathic pain and spinal microglia: a big problem from molecules in “small” glia. Trends Neurosci. 2005;28:101–107. doi: 10.1016/j.tins.2004.12.002. [DOI] [PubMed] [Google Scholar]
  • [78].Guo W., Wang H., Watanabe M., Shimizu K., Zou S., LaGraize S.C., et al. Glial-cytokine-neuronal interactions underlying the mechanisms of persistent pain. J Neurosci. 2007;27:6006–6018. doi: 10.1523/JNEUROSCI.0176-07.2007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [79].Smith H.S. Activated microglia in nociception. Pain Physician. 2010;13:295–304. [PubMed] [Google Scholar]
  • [80].Zhou D., Chen M.L., Zhang Y.Q., Zhao Z.Q. Involvement of spinal microglial P2X7 receptor in generation of tolerance to morphine analgesia in rats. J Neurosci. 2010;30:8042–8047. doi: 10.1523/JNEUROSCI.5377-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [81].Song P., Zhao Z.Q. The involvement of glial cells in the development of morphine tolerance. Neurosci Res. 2001;39:281–286. doi: 10.1016/S0168-0102(00)00226-1. [DOI] [PubMed] [Google Scholar]
  • [82].Ji R.R., Gereau R.W., Malcangio M., Strichartz G.R. MAP kinase and pain. Brain Res Rev. 2009;60:135–148. doi: 10.1016/j.brainresrev.2008.12.011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [83].Zhou L.J., Yang T., Wei X., Liu Y., Xin W.J., Chen Y., et al. Brainderived neurotrophic factor contributes to spinal long-term potentiation and mechanical hypersensitivity by activation of spinal microglia in rat. Brain Behav Immun. 2011;25:322–334. doi: 10.1016/j.bbi.2010.09.025. [DOI] [PubMed] [Google Scholar]
  • [84].Xu J.T., Xin W.J., Wei X.H., Wu C.Y., Ge Y.X., Liu Y.L., et al. p38 activation in uninjured primary afferent neurons and in spinal microglia contributes to the development of neuropathic pain induced by selective motor fiber injury. Exp Neurol. 2007;204:355–365. doi: 10.1016/j.expneurol.2006.11.016. [DOI] [PubMed] [Google Scholar]
  • [85].Kawasaki Y., Zhang L., Cheng J.K., Ji R.R. Cytokine mechanisms of central sensitization: distinct and overlapping role of interleukin-1beta, interleukin-6, and tumor necrosis factor-alpha in regulating synaptic and neuronal activity in the superficial spinal cord. J Neurosci. 2008;28:5189–5194. doi: 10.1523/JNEUROSCI.3338-07.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [86].Coull J.A., Beggs S., Boudreau D., Boivin D., Tsuda M., Inoue K., et al. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature. 2005;438:1017–1021. doi: 10.1038/nature04223. [DOI] [PubMed] [Google Scholar]
  • [87].Li J., Xie W., Zhang J.M., Baccei M.L. Peripheral nerve injury sensitizes neonatal dorsal horn neurons to tumor necrosis factor-alpha. Mol Pain. 2009;5:10. doi: 10.1186/1744-8069-5-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [88].Zhou L.J., Zhong Y., Ren W.J., Li Y.Y., Zhang T., Liu X.G. BDNF induces late-phase LTP of C-fiber evoked field potentials in rat spinal dorsal horn. Exp Neurol. 2008;212:507–514. doi: 10.1016/j.expneurol.2008.04.034. [DOI] [PubMed] [Google Scholar]
  • [89].Liu Y.L., Zhou L.J., Hu N.W., Xu J.T., Wu C.Y., Zhang T., et al. Tumor necrosis factor-alpha induces long-term potentiation of C-fiber evoked field potentials in spinal dorsal horn in rats with nerve injury: the role of NF-kappa B, JNK and p38 MAPK. Neuropharmacology. 2007;52:708–715. doi: 10.1016/j.neuropharm.2006.09.011. [DOI] [PubMed] [Google Scholar]
  • [90].Park C.K., Lu N., Xu Z.Z., Liu T., Serhan C.N., Ji R.R. Resolving TRPV1- and TNF-alpha-mediated spinal cord synaptic plasticity and inflammatory pain with neuroprotectin D1. J Neurosci. 2011;31:15072–15085. doi: 10.1523/JNEUROSCI.2443-11.2011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [91].Bsibsi M., Ravid R., Gveric D., van Noort J.M. Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol. 2002;61:1013–1021. doi: 10.1093/jnen/61.11.1013. [DOI] [PubMed] [Google Scholar]
  • [92].Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J Immunol. 2004;173:3916–3924. doi: 10.4049/jimmunol.173.6.3916. [DOI] [PubMed] [Google Scholar]
  • [93].Iliev A.I., Stringaris A.K., Nau R., Neumann H. Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9) FASEB J. 2004;18:412–414. doi: 10.1096/fj.03-0670fje. [DOI] [PubMed] [Google Scholar]
  • [94].Dalpke A.H., Schafer M.K., Frey M., Zimmermann S., Tebbe J., Weihe E., et al. Immunostimulatory CpG-DNA activates murine microglia. J Immunol. 2002;168:4854–4863. doi: 10.4049/jimmunol.168.10.4854. [DOI] [PubMed] [Google Scholar]
  • [95].Butchi N.B., Du M., Peterson K.E. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia. Glia. 2010;58:650–664. doi: 10.1002/glia.20952. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [96].Qin L., Li G., Qian X., Liu Y., Wu X., Liu B., et al. Interactive role of the toll-like receptor 4 and reactive oxygen species in LPSinduced microglia activation. Glia. 2005;52:78–84. doi: 10.1002/glia.20225. [DOI] [PubMed] [Google Scholar]
  • [97].Clark A.K., Staniland A.A., Marchand F., Kaan T.K., McMahon S.B., Malcangio M. P2X7-dependent release of interleukin-1beta and nociception in the spinal cord following lipopolysaccharide. J Neurosci. 2010;30:573–582. doi: 10.1523/JNEUROSCI.3295-09.2010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [98].Sugama S., Takenouchi T., Fujita M., Conti B., Hashimoto M. Differential microglial activation between acute stress and lipopolysaccharide treatment. J Neuroimmunol. 2009;207:24–31. doi: 10.1016/j.jneuroim.2008.11.007. [DOI] [PubMed] [Google Scholar]
  • [99].Cao L., Tanga F.Y., Deleo J.A. The contributing role of CD14 in tolllike receptor 4 dependent neuropathic pain. Neuroscience. 2009;158:896–903. doi: 10.1016/j.neuroscience.2008.10.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [100].Raghavendra V., Tanga F.Y., Deleo J.A. Complete Freunds adjuvantinduced peripheral inflammation evokes glial activation and proin-flammatory cytokine expression in the CNS. Eur J Neurosci. 2004;20:467–473. doi: 10.1111/j.1460-9568.2004.03514.x. [DOI] [PubMed] [Google Scholar]
  • [101].Wen Y.R., Tan P.H., Cheng J.K., Liu Y.C., Ji R.R. Microglia: a promising target for treating neuropathic and postoperative pain, and morphine tolerance. J Formos Med Assoc. 2011;110:487–494. doi: 10.1016/S0929-6646(11)60074-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [102].Matsui T., Svensson C.I., Hirata Y., Mizobata K., Hua X.Y., Yaksh T.L. Release of prostaglandin E(2) and nitric oxide from spinal microglia is dependent on activation of p38 mitogen-activated protein kinase. Anesth Analg. 2010;111:554–560. doi: 10.1213/ANE.0b013e3181e3a2a2. [DOI] [PubMed] [Google Scholar]
  • [103].Dityatev A., Rusakov D.A. Molecular signals of plasticity at the tetrapartite synapse. Curr Opin Neurobiol. 2011;21:353–359. doi: 10.1016/j.conb.2010.12.006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [104].Petzold G.C., Murthy V.N. Role of astrocytes in neurovascular coupling. Neuron. 2011;71:782–797. doi: 10.1016/j.neuron.2011.08.009. [DOI] [PubMed] [Google Scholar]
  • [105].Gao Y.J., Ji R.R. Activation of JNK pathway in persistent pain. Neurosci Lett. 2008;437:180–183. doi: 10.1016/j.neulet.2008.03.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [106].Ji R.R., Kawasaki Y., Zhuang Z.Y., Wen Y.R., Decosterd I. Possible role of spinal astrocytes in maintaining chronic pain sensitization: review of current evidence with focus on bFGF/JNK pathway. Neuron Glia Biol. 2006;2:259–269. doi: 10.1017/S1740925X07000403. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [107].Jiang F., Liu T., Cheng M., Pang X.Y., Bai Z.T., Zhou J.J., et al. Spinal astrocyte and microglial activation contributes to rat pain-related behaviors induced by the venom of scorpion Buthus martensi Karch. Eur J Pharmacol. 2009;623:52–64. doi: 10.1016/j.ejphar.2009.09.028. [DOI] [PubMed] [Google Scholar]
  • [108].Kawasaki Y., Xu Z.Z., Wang X., Park J.Y., Zhuang Z.Y., Tan P.H., et al. Distinct roles of matrix metalloproteases in the early- and late-phase development of neuropathic pain. Nat Med. 2008;14:331–336. doi: 10.1038/nm1723. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [109].Gao Y.J., Xu Z.Z., Liu Y.C., Wen Y.R., Decosterd I., Ji R.R. The c-Jun N-terminal kinase 1 (JNK1) in spinal astrocytes is required for the maintenance of bilateral mechanical allodynia under a persistent inflammatory pain condition. Pain. 2010;148:309–319. doi: 10.1016/j.pain.2009.11.017. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [110].Tsuda M., Kohro Y., Yano T., Tsujikawa T., Kitano J., Tozaki-Saitoh H., et al. JAK-STAT3 pathway regulates spinal astrocyte proliferation and neuropathic pain maintenance in rats. Brain. 2011;134:1127–1139. doi: 10.1093/brain/awr025. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [111].Wei F., Guo W., Zou S., Ren K., Dubner R. Supraspinal glialneuronal interactions contribute to descending pain facilitation. J Neurosci. 2008;28:10482–10495. doi: 10.1523/JNEUROSCI.3593-08.2008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [112].Ji R.R., Strichartz G. Cell signaling and the genesis of neuropathic pain. Sci STKE. 2004;2004:reE14. doi: 10.1126/stke.2522004re14. [DOI] [PubMed] [Google Scholar]
  • [113].Ji R.R., Xu Z.Z., Wang X., Lo E.H. Matrix metalloprotease regulation of neuropathic pain. Trends Pharmacol Sci. 2009;30:336–340. doi: 10.1016/j.tips.2009.04.002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [114].Wang W., Mei X.P., Wei Y.Y., Zhang M.M., Zhang T., Wang W., et al. Neuronal NR2B-containing NMDA receptor mediates spinal astrocytic c-Jun N-terminal kinase activation in a rat model of neuropathic pain. Brain Behav Immun. 2011;25:1355–1366. doi: 10.1016/j.bbi.2011.04.002. [DOI] [PubMed] [Google Scholar]
  • [115].Ren K., Dubner R. Neuron-glia crosstalk gets serious: role in pain hypersensitivity. Curr Opin Anaesthesiol. 2008;21:570–579. doi: 10.1097/ACO.0b013e32830edbdf. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [116].Ren K., Torres R. Role of interleukin-1beta during pain and inflammation. Brain Res Rev. 2009;60:57–64. doi: 10.1016/j.brainresrev.2008.12.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [117].Farina C., Aloisi F., Meinl E. Astrocytes are active players in cerebral innate immunity. Trends Immunol. 2007;28:138–145. doi: 10.1016/j.it.2007.01.005. [DOI] [PubMed] [Google Scholar]
  • [118].Carpentier P.A., Begolka W.S., Olson J.K., Elhofy A., Karpus W.J., Miller S.D. Differential activation of astrocytes by innate and adaptive immune stimuli. Glia. 2005;49:360–374. doi: 10.1002/glia.20117. [DOI] [PubMed] [Google Scholar]
  • [119].Scumpia P.O., Kelly K.M., Reeves W.H., Stevens B.R. Doublestranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia. 2005;52:153–162. doi: 10.1002/glia.20234. [DOI] [PubMed] [Google Scholar]
  • [120].Kim H., Yang E., Lee J., Kim S.H., Shin J.S., Park J.Y., et al. Doublestranded RNA mediates interferon regulatory factor 3 activation and interleukin-6 production by engaging Toll-like receptor 3 in human brain astrocytes. Immunology. 2008;124:480–488. doi: 10.1111/j.1365-2567.2007.02799.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [121].Bsibsi M., Persoon-Deen C., Verwer R.W., Meeuwsen S., Ravid R., van Noort J.M. Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia. 2006;53:688–695. doi: 10.1002/glia.20328. [DOI] [PubMed] [Google Scholar]
  • [122].Gorina R., Font-Nieves M., Marquez-Kisinousky L., Santalucia T., Planas A.M. Astrocyte TLR4 activation induces a proinflammatory environment through the interplay between MyD88-dependent NFkappaB signaling, MAPK, and Jak1/Stat1 pathways. Glia. 2011;59:242–255. doi: 10.1002/glia.21094. [DOI] [PubMed] [Google Scholar]
  • [123].Bowman C.C., Rasley A., Tranguch S.L., Marriott I. Cultured astrocytes express toll-like receptors for bacterial products. Glia. 2003;43:281–291. doi: 10.1002/glia.10256. [DOI] [PubMed] [Google Scholar]
  • [124].Hanke M.L., Kielian T. Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential. Clin Sci (Lond) 2011;121:367–387. doi: 10.1042/CS20110164. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [125].Ji R.R., Gao Y.J. Astrocyte signaling in neuropathic pain. Glia. 2011;59:S35–36. doi: 10.1002/glia.21074. [DOI] [Google Scholar]
  • [126].Wadachi R., Hargreaves K.M. Trigeminal nociceptors express TLR-4 and CD14: a mechanism for pain due to infection. J Dent Res. 2006;85:49–53. doi: 10.1177/154405910608500108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [127].Ferraz C.C., Henry M.A., Hargreaves K.M., Diogenes A. Lipopolysaccharide from Porphyromonas gingivalis sensitizes capsaicinsensitive nociceptors. J Endod. 2011;37:45–48. doi: 10.1016/j.joen.2007.07.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [128].Diogenes A., Ferraz C.C., Akopian A.N., Henry M.A., Hargreaves K.M. LPS sensitizes TRPV1 via activation of TLR4 in trigeminal sensory neurons. J Dent Res. 2011;90:759–764. doi: 10.1177/0022034511400225. [DOI] [PubMed] [Google Scholar]
  • [129].Acosta C., Davies A. Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons. J Neurosci Res. 2008;86:1077–1086. doi: 10.1002/jnr.21565. [DOI] [PubMed] [Google Scholar]
  • [130].Liu T., Xu Z.Z., Park C.K., Berta T., Ji R.R. Toll-like receptor 7 mediates pruritus. Nat Neurosci. 2010;13:1460–1462. doi: 10.1038/nn.2683. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [131].Ikoma A., Steinhoff M., Stander S., Yosipovitch G., Schmelz M. The neurobiology of itch. Nat Rev Neurosci. 2006;7:535–547. doi: 10.1038/nrn1950. [DOI] [PubMed] [Google Scholar]
  • [132].Bieber T. Atopic dermatitis. N Engl J Med. 2008;358:1483–1494. doi: 10.1056/NEJMra074081. [DOI] [PubMed] [Google Scholar]
  • [133].Reich A., Szepietowski J.C. Mediators of pruritus in psoriasis. Mediators Inflamm. 2007;2007:64727. doi: 10.1155/2007/64727. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [134].Kremer A.E., Martens J.J., Kulik W., Rueff F., Kuiper E.M., van Buuren H.R., et al. Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology. 2010;139:1008–1018. doi: 10.1053/j.gastro.2010.05.009. [DOI] [PubMed] [Google Scholar]
  • [135].Cassano N., Tessari G., Vena G.A., Girolomoni G. Chronic pruritus in the absence of specific skin disease: an update on pathophysiology, diagnosis, and therapy. Am J Clin Dermatol. 2010;11:399–411. doi: 10.2165/11317620-000000000-00000. [DOI] [PubMed] [Google Scholar]
  • [136].Yamaoka H., Sasaki H., Yamasaki H., Ogawa K., Ohta T., Furuta H., et al. Truncal pruritus of unknown origin may be a symptom of diabetic polyneuropathy. Diabetes Care. 2010;33:150–155. doi: 10.2337/dc09-0632. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [137].Paus R., Schmelz M., Biro T., Steinhoff M. Frontiers in pruritus research: scratching the brain for more effective itch therapy. J Clin Invest. 2006;116:1174–1186. doi: 10.1172/JCI28553. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [138].Imamachi N., Park G.H., Lee H., Anderson D.J., Simon M.I., Basbaum A.I., et al. TRPV1-expressing primary afferents generate behavioral responses to pruritogens via multiple mechanisms. Proc Natl Acad Sci U S A. 2009;106:11330–11335. doi: 10.1073/pnas.0905605106. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [139].Mishra S.K., Tisel S.M., Orestes P., Bhangoo S.K., Hoon M.A. TRPV1-lineage neurons are required for thermal sensation. EMBO J. 2011;30:582–593. doi: 10.1038/emboj.2010.325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [140].Sun Y.G., Zhao Z.Q., Meng X.L., Yin J., Liu X.Y., Chen Z.F. Cellular basis of itch sensation. Science. 2009;325:1531–1534. doi: 10.1126/science.1174868. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [141].Sun Y.G., Chen Z.F. A gastrin-releasing peptide receptor mediates the itch sensation in the spinal cord. Nature. 2007;448:700–703. doi: 10.1038/nature06029. [DOI] [PubMed] [Google Scholar]
  • [142].Hemmi H., Kaisho T., Takeuchi O., Sato S., Sanjo H., Hoshino K., et al. Small anti-viral compounds activate immune cells via the TLR7 MyD88-dependent signaling pathway. Nat Immunol. 2002;3:196–200. doi: 10.1038/ni758. [DOI] [PubMed] [Google Scholar]
  • [143].Kim S.J., Park G.H., Kim D., Lee J., Min H., Wall E., et al. Analysis of cellular and behavioral responses to imiquimod reveals a unique itch pathway in transient receptor potential vanilloid 1 (TRPV1)-expressing neurons. Proc Natl Acad Sci U S A. 2011;108:3371–3376. doi: 10.1073/pnas.1019755108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [144].Schon M.P., Schon M., Klotz K.N. The small antitumoral immune response modifier imiquimod interacts with adenosine receptor signaling in a TLR7- and TLR8-independent fashion. J Invest Dermatol. 2006;126:1338–1347. doi: 10.1038/sj.jid.5700286. [DOI] [PubMed] [Google Scholar]
  • [145].Kaufman E.H., Fryer A.D., Jacoby D.B. Toll-like receptor 7 agonists are potent and rapid bronchodilators in guinea pigs. J Allergy Clin Immunol. 2011;127:462–469. doi: 10.1016/j.jaci.2010.10.029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [146].Lai Y., Gallo R.L. Toll-like receptors in skin infections and inflammatory diseases. Infect Disord Drug Targets. 2008;8:144–155. doi: 10.2174/1871526510808030144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [147].Miller L.S. Toll-like receptors in skin. Adv Dermatol. 2008;24:71–87. doi: 10.1016/j.yadr.2008.09.004. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [148].Meyer T., Stockfleth E., Christophers E. Immune response profiles in human skin. Br J Dermatol. 2007;157(Suppl2):1–7. doi: 10.1111/j.1365-2133.2007.08264.x. [DOI] [PubMed] [Google Scholar]
  • [149].Chen J. History of pain theories. Neurosci Bull. 2011;27:343–350. doi: 10.1007/s12264-011-0139-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • [150].Kini S.P., Delong L.K., Veledar E., McKenzie-Brown A.M., Schaufele M., Chen S.C. The impact of pruritus on quality of life: The skin equivalent of pain. Arch Dermatol. 2011;147:1153–1156. doi: 10.1001/archdermatol.2011.178. [DOI] [PubMed] [Google Scholar]
  • [151].Liu Q., Tang Z., Surdenikova L., Kim S., Patel K.N., Kim A., et al. Sensory neuron-specific GPCR Mrgprs are itch receptors mediating chloroquine-induced pruritus. Cell. 2009;139:1353–1365. doi: 10.1016/j.cell.2009.11.034. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Neuroscience Bulletin are provided here courtesy of Springer

RESOURCES